From December 6, 2022 to December 31, 2022, the company has repurchased 1,696,100 shares, representing 0.18% for CNY 55.93 million. With this, the company has completed the repurchase of 1,696,100 shares, representing 0.18% for CNY 55.93 million under the buyback announced on December 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.2 CNY | -2.74% |
|
-3.49% | +3.40% |
06-28 | Livzon Pharmaceutical Group Cancels Repurchased Shares | MT |
06-20 | India's Biocon seeks partner to test generic Wegovy, Ozempic in China | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.40% | 4.07B | |
+54.07% | 809B | |
+39.16% | 624B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.75% | 240B | |
+0.57% | 219B | |
+14.58% | 220B | |
+7.42% | 166B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Tranche Update on Livzon Pharmaceutical Group Inc.'s Equity Buyback Plan announced on December 6, 2022.